These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 35628578)

  • 61. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
    Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
    Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The influence of 5-HTTLPR and Val66Met polymorphisms on cortical thickness and volume in limbic and paralimbic regions in depression: a preliminary study.
    Jaworska N; MacMaster FP; Foster J; Ramasubbu R
    BMC Psychiatry; 2016 Mar; 16():61. PubMed ID: 26976307
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Structural alterations of the brain preceded functional alterations in major depressive disorder patients: Evidence from multimodal connectivity.
    Yao Z; Zou Y; Zheng W; Zhang Z; Li Y; Yu Y; Zhang Z; Fu Y; Shi J; Zhang W; Wu X; Hu B
    J Affect Disord; 2019 Jun; 253():107-117. PubMed ID: 31035211
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Melatonin Attenuates LPS-Induced Acute Depressive-Like Behaviors and Microglial NLRP3 Inflammasome Activation Through the SIRT1/Nrf2 Pathway.
    Arioz BI; Tastan B; Tarakcioglu E; Tufekci KU; Olcum M; Ersoy N; Bagriyanik A; Genc K; Genc S
    Front Immunol; 2019; 10():1511. PubMed ID: 31327964
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Regional cortical thinning in patients with major depressive disorder: a surface-based morphometry study.
    Tu PC; Chen LF; Hsieh JC; Bai YM; Li CT; Su TP
    Psychiatry Res; 2012 Jun; 202(3):206-13. PubMed ID: 22521631
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Multimodal and multiscale evidence for network-based cortical thinning in major depressive disorder.
    Li J; Wang R; Mao N; Huang M; Qiu S; Wang J
    Neuroimage; 2023 Aug; 277():120265. PubMed ID: 37414234
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Regional increases of cortical thickness in untreated, first-episode major depressive disorder.
    Qiu L; Lui S; Kuang W; Huang X; Li J; Li J; Zhang J; Chen H; Sweeney JA; Gong Q
    Transl Psychiatry; 2014 Apr; 4(4):e378. PubMed ID: 24713859
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Epigenetic Changes of FKBP5 as a Link Connecting Genetic and Environmental Risk Factors with Structural and Functional Brain Changes in Major Depression.
    Tozzi L; Farrell C; Booij L; Doolin K; Nemoda Z; Szyf M; Pomares FB; Chiarella J; O'Keane V; Frodl T
    Neuropsychopharmacology; 2018 Apr; 43(5):1138-1145. PubMed ID: 29182159
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In vivo relationship between serotonin 1A receptor binding and gray matter volume in the healthy brain and in major depressive disorder.
    Zanderigo F; Pantazatos S; Rubin-Falcone H; Ogden RT; Chhetry BT; Sullivan G; Oquendo M; Miller JM; Mann JJ
    Brain Struct Funct; 2018 Jul; 223(6):2609-2625. PubMed ID: 29550938
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Influence and interaction of resting state functional magnetic resonance and tryptophan hydroxylase-2 methylation on short-term antidepressant drug response.
    Tan T; Xu Z; Gao C; Shen T; Li L; Chen Z; Chen L; Xu M; Chen B; Liu J; Zhang Z; Yuan Y
    BMC Psychiatry; 2022 Mar; 22(1):218. PubMed ID: 35337298
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Genome-wide profiling of DNA methylome and transcriptome in peripheral blood monocytes for major depression: A Monozygotic Discordant Twin Study.
    Zhu Y; Strachan E; Fowler E; Bacus T; Roy-Byrne P; Zhao J
    Transl Psychiatry; 2019 Sep; 9(1):215. PubMed ID: 31477685
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cortical abnormalities and association with symptom dimensions across the depressive spectrum.
    Lener MS; Kundu P; Wong E; Dewilde KE; Tang CY; Balchandani P; Murrough JW
    J Affect Disord; 2016 Jan; 190():529-536. PubMed ID: 26571102
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Microbiota-Inflammasome Hypothesis of Major Depression.
    Inserra A; Rogers GB; Licinio J; Wong ML
    Bioessays; 2018 Sep; 40(9):e1800027. PubMed ID: 30004130
    [TBL] [Abstract][Full Text] [Related]  

  • 74. How do substance use disorders compare to other psychiatric conditions on structural brain abnormalities? A cross-disorder meta-analytic comparison using the ENIGMA consortium findings.
    Navarri X; Afzali MH; Lavoie J; Sinha R; Stein DJ; Momenan R; Veltman DJ; Korucuoglu O; Sjoerds Z; van Holst RJ; Hester R; Orr C; Cousijn J; Yucel M; Lorenzetti V; Wiers R; Jahanshad N; Glahn DC; Thompson PM; Mackey S; Conrod PJ
    Hum Brain Mapp; 2022 Jan; 43(1):399-413. PubMed ID: 32643841
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The effect of polygenic risk scores for major depressive disorder, bipolar disorder and schizophrenia on morphological brain measures: A systematic review of the evidence.
    Cattarinussi G; Delvecchio G; Sambataro F; Brambilla P
    J Affect Disord; 2022 Aug; 310():213-222. PubMed ID: 35533776
    [TBL] [Abstract][Full Text] [Related]  

  • 76. DNA methylation of the serotonin transporter gene in peripheral cells and stress-related changes in hippocampal volume: a study in depressed patients and healthy controls.
    Booij L; Szyf M; Carballedo A; Frey EM; Morris D; Dymov S; Vaisheva F; Ly V; Fahey C; Meaney J; Gill M; Frodl T
    PLoS One; 2015; 10(3):e0119061. PubMed ID: 25781010
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Age-related atrophy of cortical thickness and genetic effect of ANK3 gene in first episode MDD patients.
    Cheng Y; Xu J; Dong C; Shen Z; Zhou C; Li N; Lu Y; Ran L; Xu L; Shan B; Xu X
    Neuroimage Clin; 2020; 28():102384. PubMed ID: 32911427
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Distinguishing bipolar and major depressive disorders by brain structural morphometry: a pilot study.
    Fung G; Deng Y; Zhao Q; Li Z; Qu M; Li K; Zeng YW; Jin Z; Ma YT; Yu X; Wang ZR; Shum DH; Chan RC
    BMC Psychiatry; 2015 Nov; 15():298. PubMed ID: 26590556
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Longitudinal brain volume changes in major depressive disorder.
    Yüksel D; Engelen J; Schuster V; Dietsche B; Konrad C; Jansen A; Dannlowski U; Kircher T; Krug A
    J Neural Transm (Vienna); 2018 Oct; 125(10):1433-1447. PubMed ID: 30167933
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Characterizing the subtype of anhedonia in major depressive disorder: A symptom-specific multimodal MRI study.
    Liu X; Li L; Li M; Ren Z; Ma P
    Psychiatry Res Neuroimaging; 2021 Feb; 308():111239. PubMed ID: 33453684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.